IBDEI0ON ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12079,0)
 ;;=305.41^^66^728^25
 ;;^UTILITY(U,$J,358.3,12079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12079,1,2,0)
 ;;=2^305.41
 ;;^UTILITY(U,$J,358.3,12079,1,5,0)
 ;;=5^Anxiolytic Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,12079,2)
 ;;=^331936
 ;;^UTILITY(U,$J,358.3,12080,0)
 ;;=305.42^^66^728^26
 ;;^UTILITY(U,$J,358.3,12080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12080,1,2,0)
 ;;=2^305.42
 ;;^UTILITY(U,$J,358.3,12080,1,5,0)
 ;;=5^Anxiolytic Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,12080,2)
 ;;=^331937
 ;;^UTILITY(U,$J,358.3,12081,0)
 ;;=305.51^^66^728^69
 ;;^UTILITY(U,$J,358.3,12081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12081,1,2,0)
 ;;=2^305.51
 ;;^UTILITY(U,$J,358.3,12081,1,5,0)
 ;;=5^Opioid Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,12081,2)
 ;;=^268244
 ;;^UTILITY(U,$J,358.3,12082,0)
 ;;=305.52^^66^728^70
 ;;^UTILITY(U,$J,358.3,12082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12082,1,2,0)
 ;;=2^305.52
 ;;^UTILITY(U,$J,358.3,12082,1,5,0)
 ;;=5^Opioid Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,12082,2)
 ;;=^268245
 ;;^UTILITY(U,$J,358.3,12083,0)
 ;;=305.61^^66^728^41
 ;;^UTILITY(U,$J,358.3,12083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12083,1,2,0)
 ;;=2^305.61
 ;;^UTILITY(U,$J,358.3,12083,1,5,0)
 ;;=5^Cocaine Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,12083,2)
 ;;=^268247
 ;;^UTILITY(U,$J,358.3,12084,0)
 ;;=305.62^^66^728^42
 ;;^UTILITY(U,$J,358.3,12084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12084,1,2,0)
 ;;=2^305.62
 ;;^UTILITY(U,$J,358.3,12084,1,5,0)
 ;;=5^Cocaine Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,12084,2)
 ;;=^268248
 ;;^UTILITY(U,$J,358.3,12085,0)
 ;;=305.71^^66^728^17
 ;;^UTILITY(U,$J,358.3,12085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12085,1,2,0)
 ;;=2^305.71
 ;;^UTILITY(U,$J,358.3,12085,1,5,0)
 ;;=5^Amphetamine Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,12085,2)
 ;;=^268251
 ;;^UTILITY(U,$J,358.3,12086,0)
 ;;=305.72^^66^728^18
 ;;^UTILITY(U,$J,358.3,12086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12086,1,2,0)
 ;;=2^305.72
 ;;^UTILITY(U,$J,358.3,12086,1,5,0)
 ;;=5^Amphetamine Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,12086,2)
 ;;=^268252
 ;;^UTILITY(U,$J,358.3,12087,0)
 ;;=305.91^^66^728^77
 ;;^UTILITY(U,$J,358.3,12087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12087,1,2,0)
 ;;=2^305.91
 ;;^UTILITY(U,$J,358.3,12087,1,5,0)
 ;;=5^Other Drug Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,12087,2)
 ;;=^268259
 ;;^UTILITY(U,$J,358.3,12088,0)
 ;;=305.92^^66^728^78
 ;;^UTILITY(U,$J,358.3,12088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12088,1,2,0)
 ;;=2^305.92
 ;;^UTILITY(U,$J,358.3,12088,1,5,0)
 ;;=5^Other Drug Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,12088,2)
 ;;=^268260
 ;;^UTILITY(U,$J,358.3,12089,0)
 ;;=V65.2^^66^729^33
 ;;^UTILITY(U,$J,358.3,12089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12089,1,2,0)
 ;;=2^V65.2
 ;;^UTILITY(U,$J,358.3,12089,1,5,0)
 ;;=5^Malingering
 ;;^UTILITY(U,$J,358.3,12089,2)
 ;;=^92393
 ;;^UTILITY(U,$J,358.3,12090,0)
 ;;=V65.49^^66^729^38
 ;;^UTILITY(U,$J,358.3,12090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12090,1,2,0)
 ;;=2^V65.49
 ;;^UTILITY(U,$J,358.3,12090,1,5,0)
 ;;=5^Other Specified Counseling
 ;;^UTILITY(U,$J,358.3,12090,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,12091,0)
 ;;=V61.10^^66^729^43
 ;;^UTILITY(U,$J,358.3,12091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12091,1,2,0)
 ;;=2^V61.10
 ;;^UTILITY(U,$J,358.3,12091,1,5,0)
 ;;=5^Partner Relational Problem
 ;;^UTILITY(U,$J,358.3,12091,2)
 ;;=^74110
 ;;^UTILITY(U,$J,358.3,12092,0)
 ;;=V61.20^^66^729^41
 ;;^UTILITY(U,$J,358.3,12092,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12092,1,2,0)
 ;;=2^V61.20
